In reality, while there are ample similarities where some view AL amyloidosis and multiple myeloma as “cousins,” there are important differences.
amyloidosis treatment
CRISPR/Cas9 – Editing the Code of Life
The scientific world is abuzz … a Nobel Prize-winning technology called CRISPR/Cas9 can now edit our DNA. This programmable gene-editing technology, which is efficient, precise, and scalable, has inspired a gold rush of countless applications in medicine, agriculture and basic science. In this blog we invite you to read more about this ground-breaking advance and how, with one course of treatment, it could potentially cure hereditary transthyretin (hATTR / ATTRv) amyloidosis.
